Agilon Health (AGL) Equity Average (2020 - 2025)
Agilon Health (AGL) has disclosed Equity Average for 6 consecutive years, with $216.4 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Equity Average fell 58.62% year-over-year to $216.4 million, compared with a TTM value of $216.4 million through Dec 2025, down 58.62%, and an annual FY2025 reading of $298.8 million, down 47.2% over the prior year.
- Equity Average was $216.4 million for Q4 2025 at Agilon Health, down from $357.5 million in the prior quarter.
- Across five years, Equity Average topped out at $1.1 billion in Q3 2021 and bottomed at -$291.5 million in Q1 2021.
- Average Equity Average over 5 years is $722.6 million, with a median of $724.2 million recorded in 2023.
- The sharpest move saw Equity Average surged 546.12% in 2021, then tumbled 58.62% in 2025.
- Year by year, Equity Average stood at $1.1 billion in 2021, then dropped by 4.2% to $1.1 billion in 2022, then fell by 27.91% to $766.3 million in 2023, then crashed by 31.76% to $522.9 million in 2024, then tumbled by 58.62% to $216.4 million in 2025.
- Business Quant data shows Equity Average for AGL at $216.4 million in Q4 2025, $357.5 million in Q3 2025, and $454.6 million in Q2 2025.